Lunch Workshops

REQUIRED: Separate registration fee of $50.00; includes a box lunch and CME credits. Participation is limited to 75 so register early.

Wednesday, April 23, 12:00pm - 2:00pm

What the Nephrologist Needs to Know to Manage the Pregnant Patient

Session 230

Chairs: Michelle Hladunewich, MD, and Shaoling Zhang, MD
Presenters: Heidi Schaefer, MD, FNKF, Michelle Hladunewich, MD, and Tina Podymow, MD
This workshop will use a case-based approach to review "What the Nephrologist Needs to Know to Manage the Pregnant Patient." The first topic covered will review the management of renal transplants during pregnancy. The second will review the management of pregnant patients with kidney disease, including pre-eclampsia. The final topic will review dialysis management during pregnancy.

Choosing the Hemodiaylsate Bath: An Update

Session 231

Chairs: Alfred Cheung, MD, FNKF
Presenters: Brigitte Schiller, MD, Raymond Hakim, MD, PhD, Francesca Tentori, MD, and Deborah Zimmerman, MD
The composition of the hemodialysate bath is an often overlooked but critical aspect of providing dialysis, and the optimal composition of the dialysate remains controversial. With uncertainty on topics like: sodium modeling and sodium balance; whether a 1K bath is safe; issues relating to bicarbonate concentrations that have spawned lawsuits across the U.S.; and one recent publication suggesting risks with low calcium baths that contrast a push toward avoidance of modest hypercalcemia; prescribing the optimal dialysate bath represents a considerable challenge to dialysis professionals. This workshop will provide an overview of the current best evidence for optimizing the dialysate for individual patients, helping participants make the best choices for their patients.

Fistula First/Cather Last

Session 232

Chair: Timmy Lee, MD, MSPH, FACP, FASN, FNKF, and Joseph Vassalotti, MD, FASN, FNKF
Presenters: Tushar Vachharajani, MD, FASN, FACP, and Michael Allon, MD
This workshop will provide a practical and evidence based review of the impact of Fistula First Initiative on fistula use in the United States, and the future role of the Fistula First Initiative to reduce dialysis catheter use. Moreover, there will be an in-depth talk on the role of the interventionalist to further improve fistula use and reduce catheter prevalence. This will be a unique opportunity for interactive learning between the audience and internationally recognized experts in the field of vascular access.

Nephrotic Syndrome in 2014

Session 233

Chairs: Daniel Cattran, MD, and Debbie Gipson, MD, FNKF
Presenters: Debbie Gipson, MD, FNKF, Cynthia Nast, MD, and Daniel Cattran, MD
This workshop will provide attendees with an overview of the epidemiology of nephrotic syndrome and associated conditions and the prognostic importance of the biopsy on clinical care, and will review evidence-based guidelines for patient management. Practical aspects of managing the nephrotic patient will be discussed, including tailoring treatment based on proteinuria and eGFR, complication prevention strategies, and a review of the new findings ready for the clinical arena.

Growing Fast: Challenges for Hispanic Patients with CKD

Session 234

Chair: Sylvia E. Rosas, MD, MSCE, FNKF, and Carmen Peralta, MD
Presenters: Sylvia E. Rosas, MD, MSCE, FNKF, Claudia Lora, MD, MS, and Cristina Arce, MD, MS
Hispanic individuals constitute the largest and fastest growing minority in the U.S. Hispanics are at particular risk of kidney disease and face particular challenges in their access to and delivery of care. This session will provide an overview of the epidemiology and outcomes of kidney disease in the Hispanic minority, and will focus on particular issues in delivering culturally competent care. In addition, we will cover the special challenge of caring for undocumented immigrants who require treatment for ESRD.


Session 235

Chair: Kamel Kamel, MD, FRCPC
Presenters: Mark Perazella, MD, FNKF, Kamel Kamel, MD, FRCPC and Joseph Verbalis, MD
This session will cover three complex clinical areas that relate to and are critical for the practicing nephrologist. The first topic will review the clinical presentation and management of acid-base abnormalities that occur as a result of toxic ingestions. The second will review the use of aquaporin-2 antagonists in chronic hyponatremia and kidney diseases, including polycystic disease. The final topic will review clinical manifestations, including electrolyte disturbances and nephrotoxicity of recreational drug ingestion and related management strategies. Each session will include the presentation of a few interesting cases in an interactive format with the audience.

Nuts n' Bolts of Home HD: Part 1 - Set-Up

Session 236

Chair: Charmaine Lok, MD, MSc, FNKF, and Christopher Chan, MD, FRCPC
Presenters: Robert Lockridge, MD, Christopher Chan, MD, FRCPC, MPH, and Alan Kliger, MD
Attendees of this workshop will learn how to implement a successful home hemodialysis program and understand strategies for recruitment of home hemodialysis patients. It will also provide an overview of how to develop and ensure a quality initiative in your home hemodialysis program.

Friday, April 25, 11:30am - 1:00pm

Controversies in the Management of Hypertension in Dialysis Patients

Session 237

Chair: Wendy St. Peter, PharmD, FCCP, FASN, FNKF
Presenters: Aldo Peixoto, MD, Wendy St. Peter, PharmD, FCCP, FASN, FNKF, and Tara Chang, MD, MS
Treating hypertension in both peritoneal and hemodialysis patients is complex, and involves many factors, such as dry weight estimation, volume gain and shifts during treatment, interdialytic changes in blood pressure, and limited data supporting the efficacy and evidence base for various antihypertensives. Choosing the appropriate blood pressure target and optimal medication in peritoneal and hemodialysis patients can be challenging. Gaining a working knowledge base of the data supporting various management strategies and blood pressure targets will help clinicians optimally manage hypertension in these patients. This workshop will provide participants with an evaluation of the current state of the literature in relation to blood pressure targets, and will focus on the utility and evidence base for the use of ace inhibitors and diuretics in these patients.

Key Topics in Hemodialysis Management

Session 238

Chair: Alfred K. Cheung, MD, FNKF, and Timmy Lee, MD, MSPH, FACP, FASN, FNKF
Presenters: Raymond Hakim, MD, PhD, Deborah Zimmerman, MD, and Daniel Coyne, MD
The majority of dialysis patients still utilize hemodialysis as their primary form of renal replacement therapy, but mortality rates still remain high. Management of key issues of the dialysis procedure such as blood pressure and dry weight, volume and solute removal, and cannulation techniques remains a challenge when delivering care for the hemodialysis patient. This workshop will provide an overview of these major clinical challenges and whether optimization of any of these techniques can improve morbidity and mortality for the hemodialysis patient. The workshop will provide a forum and opportunity for interaction with faculty with expertise in these areas.

PD Primer

Session 239

Chair: Claudio Ronco, MD, FNKF, and Joni Hansson, MD, FNKF
Presenters: Matthew Oliver, MD, FNKF, Joni Hansson, MD, FNKF, and William Salzer, MD
This workshop will lay the foundation for a better understanding of the fundamental principles of peritoneal dialysis (PD). Peritoneal membrane physiology, ultrafiltration, the Peritoneal Equilibration Test (PET), and use of standard PD solutions will be reviewed. Practical and innovative approaches to prescribing PD to achieve adequate dialysis will be presented. The session will conclude with a discussion of diagnosing and treating peritonitis. The ultimate goal of this workshop is to help the clinician feel more comfortable managing a patient on peritoneal dialysis.

Managing the Pre-ESRD Patient

Session 240

Chair: Michal Melamed, MD, MHS, FNKF
Presenters: Jerry Yee, MD, FNKF, FASN, FNKF Carolyn Cochran, MS, RD, LD, CDE, and Jeffrey Berns, MD, FNKF
The management of the pre- ESRD patient is often a complex balance of dietary, medication, and other interventions in preparation for dialysis. As kidney function deteriorates, medication safety, nutrition, and discussions of renal replacement therapy become increasingly important. During this workshop, important classes of medications that need monitoring or stopping will be reviewed. A dietitian will review dietary recommendations for late-stage CKD, when kidney function is almost gone, but patients are not yet on renal replacement therapy. Lastly, guiding patients and their families in a timely fashion towards appropriate renal replacement therapy options will be reviewed. This workshop will present a unique opportunity to discuss last-minute strategies for keeping patients safe and healthy before initiation of dialysis.

Palliative Care and Initiation of Dialysis in the Elderly: Can 'Opposites' Attract?

Session 241

Chairs: Dena Rifkin, MD, MS, FNKF, and Manjula Kurella Tamura, MD, MPH
Presenters: Alvin Moss, MD, Manjula Kurella Tamura, MD, MPH, and Tracy Greene-Mintz, MSW
The initiation of chronic dialysis support in an older individual marks a pivotal moment in life, one which is both a time of "life-saving" intervention and a time when issues of mortality and realistic life expectancy may arise. Traditionally, involvement of palliative care has been seen as an "either-or" choice versus an "aggressive" interventional course including renal replacement therapy. Can these two approaches to care be merged if life expectancy of the older patient is short? How should caregivers weigh the pros and cons of approaching initiation of dialysis and end-of-life in tandem? Panelists will explore these issues through realistic cases and discussion.

Kidney Stone Update for Nephrologists

Session 242

Chair: Kamel Kamel, MD, FRCPC
Presenters: Kamel Kamel, MD, Andrew Rule, MD, MSc, and Benjamin Chung, MD
The nephrologist should play an important role in the management of kidney stones. Yet the exposure of nephrologists to stone management during fellowship training and in postgraduate educational programs is often inconsistent. In this session, the speakers will discuss recent data on the potential long-term effects of kidney stones on kidney function, as well as the up-to-date medical management and non-medical treatment of kidney stones.

Nuts n' Bolts of Home HD: Part II - Maintenance

Session 243

Chairs: Charmaine Lok, MD, MSc, FNKF, and Christopher Chan, MD, FRCPC
Presenters: Robert Lockridge, MD, Joanne Bargman, MD, FRCPC, and Mark Unruh, MD
This workshop will provide an understanding of how to prevent vascular complications in home dialysis. Attendees will learn how to establish a fully integrated home dialysis program, and recognize the importance of caregiver burden and psychosocial aspects of home hemodialysis.